Skip to content

Study of efficacy and tolerability of combination therapy with low-volume polyethylene glycol (Moviprep), sodium picosulfate hydrate (pursennid), mosapride citrate hydrate (gasmotin) on bowel preparation.

Study of efficacy and tolerability of combination therapy with low-volume polyethylene glycol (Moviprep), sodium picosulfate hydrate (pursennid), mosapride citrate hydrate (gasmotin) on bowel preparation. - Study of efficacy and tolerability of combination therapy with low-volume polyethylene glycol (Moviprep), sodium picosulfate hydrate (pursennid), mosapride citrate hydrate (gasmotin) on bowel preparation.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000012518
Enrollment
50
Registered
2013-12-09
Start date
2013-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel preparation for colonoscopy

Interventions

Bowel preparation with moviprep in combination with pursennid and gasmotin.

Sponsors

Department of Gastroenterology, Juntendo University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Out or inpatients who underwent colonoscopy in our hospital. 2.Patients provided a written informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients who has obstruction and/or suspicious obstruction of gastrointestinal tract 2.Patients who has intestinal perforation 3.Patients who has delayed exhaust in stomach 4.Patients with toxic megacolon. 5. Patients 65 years of age or older 6. Patients with aphasia

Design outcomes

Primary

MeasureTime frame
Bowel cleansing level on colonoscopy

Secondary

MeasureTime frame
Evaluation of colonoscopic performer -bowel cleaning level -time to completion of bowel cleansing - smoothness of the scope Safety and tolerability

Countries

Japan

Contacts

Public ContactTomoyoshi Shibuya

Juntendo University Gastroenterology

tomoyosi@juntendo.ac.jp+81-3-5802-1058

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026